Research Article
Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study
Table 4
Association between CK17 expression and clinicopathologic parameters of patients with OSCC.
| Clinicopathologic parameters | No. of patients (%) | 0 | 1 | Score | 2 | 3 | value |
| Agea | ≤60 | 50 (60.2) | 5 | 19 | | 14 | 12 | 0.7036 | >60 | 33 (39.8) | 4 | 13 | | 9 | 7 |
| Sexa | Male | 50 (60.2) | 5 | 21 | | 15 | 9 | 0.3456 | Female | 33 (39.8) | 3 | 11 | | 10 | 9 |
| Localizationa | Tongue | 42 (50.6) | 2 | 17 | | 13 | 10 | 0.3641 | Nontongue | 41 (49.4) | 6 | 15 | | 12 | 8 |
| Clinical stageb | Stages 1 + 2 | 24 (35.3) | 3 | 10 | | 6 | 5 | 0.4789 | Stages 3 + 4 | 44 (64.7) | 4 | 15 | | 15 | 10 |
| T classificationb | T1 + T2 | 46 (67.6) | 5 | 19 | | 13 | 9 | 0.2851 | T3 + T4 | 22 (32.4) | 2 | 6 | | 8 | 6 |
| Regional lymph node metastasisb | Negative | 30 (44.1) | 4 | 12 | | 7 | 7 | 0.5142 | Positive | 38 (55.9) | 3 | 13 | | 14 | 8 |
| Histopathologic gradea | Well | 44 (53.0) | 3 | 12 | | 17 | 12 | 0.0143 | Moderate + Poor | 39 (47.0) | 5 | 20 | | 8 | 6 |
|
|
Statistically significant. a83 cases. b68 cases. |